Brief: Horizon Therapeutics To Acquire Viela Bio For USD 3.05 Bln
01/02/2021 17:02
Feb 1 (Reuters) - HBM HEALTHCARE INVESTMENTS AG HBMN.S :
* HORIZON THERAPEUTICS TO ACQUIRE HBM PORTFOLIO COMPANY
VIELA BIO
FOR USD 3.05 BILLION IN CASH
* HBM HEALTHCARE INVESTMENTS AG - COMPANIES HAVE ENTERED
INTO A
DEFINITIVE AGREEMENT UNDER WHICH HORIZON WILL ACQUIRE ALL OF
ISSUED AND OUTSTANDING SHARES OF VIELA BIO FOR USD 53.00 PER
SHARE IN CASH
* HBM HEALTHCARE INVESTMENTS AG - DEAL IS EXPECTED TO CLOSE
BY END
OF Q1 2021
Source text for Eikon: ID:nEQ2Ld3Zja
Further company coverage: HBMN.S
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 6600;))
Recent news on HBM Healthcare Investments AG
See all newsSwiss stocks - Factors to watch on October 23
Brief: HBM Healthcare Investments Reports Q1 Profit CHF 238 Million
Brief: HBM Healthcare Investments Posts Profit Of CHF 272 Million
Brief: SK Capital Is Said To Near Deal For Swiss Drug Distributor Swixx That Could Value Co At About 1.5 Billion Euros- Bloomberg News
Brief: Mirum Pharmaceuticals To Acquire HBM Portfolio Company Bluejay Therapeutics